Immune to Cancer: The CRI Blog
-
A “White Out” at the NBC TODAY Show Plaza
On Monday, June 20, the Cancer Research Institute visited the NBC TODAY Show Plaza to raise public…
-
ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells
Adoptive T cell therapies provide success against some cancers, hope for several others.
-
Together, we can #WhiteOutCancer!
This year we’re on a mission to White Out Cancer—and we need your help!
-
ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress
Improved approaches for treating patients with melanoma.
-
ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers
Immunotherapy approaches provide improvements for patients with head and neck cancer.
-
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2016
Hear from CRI's panel of immunotherapy experts—Drs. Andrew Sikora, Leena Gandhi, and Michel Sadelain—on what patients should…
-
ASCO 2016 Update: Beyond Checkpoint Blockade: Novel Immunotherapy Strategies for Solid Cancers
New strategies use alternative ways to promote anti-cancer immunity.
-
ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers
Improving immunotherapy for breast, ovarian, and gynecological cancer patients.
-
ASCO 2016 Update: Checkpoint Immunotherapy Advances in Solid Cancers
New insights, approaches to improve outcomes in melanoma, kidney, bladder, and colorectal cancers.

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.